Literature DB >> 10771991

Management of idiopathic thrombocytopenic purpura.

V P Choudhry1, R Kashyap, H P Pati.   

Abstract

Idiopathic thrombocytopenic purpura is not an uncommon bleeding disorder with a prevalence of 40-80 per million children per year. Over the last six decades, the subject of ITP has attracted the attention of pediatricians and hematologists. It is one of the subjects which has many controversies because of its unpredictable course heralded by remission relapses, and chronicity with mortality in less than 1% of cases. In the present review only the controversies in the management of acute and chronic ITP have been reviewed as it interests most pediatricians. Management of intracranial hemorrhage (ICH), severe gastrointestinal hemorrhage and menorrhagia continues to still remain a challenge in spite of newer therapies.

Entities:  

Mesh:

Year:  1998        PMID: 10771991     DOI: 10.1007/bf02761134

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  18 in total

1.  Controversies in the management of acute idiopathic thrombocytopenic purpura: a survey of specialists.

Authors:  A S Dubansky; F A Oski
Journal:  Pediatrics       Date:  1986-01       Impact factor: 7.124

2.  Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura.

Authors:  V Blanchette; P Imbach; M Andrew; M Adams; J McMillan; E Wang; R Milner; K Ali; D Barnard; M Bernstein
Journal:  Lancet       Date:  1994-09-10       Impact factor: 79.321

3.  Immunoadsorption with protein A sepharose or silica.

Authors:  M Belák; R A Widder; R Brunner; H Borberg; W F Haupt
Journal:  Lancet       Date:  1994-03-26       Impact factor: 79.321

4.  Acute immune thrombocytopenic purpura: a comparative study of very high oral doses of methylprednisolone and intravenously administered immune globulin.

Authors:  D Albayrak; I Işlek; A G Kalaycí; N Gürses
Journal:  J Pediatr       Date:  1994-12       Impact factor: 4.406

5.  Improvement of platelet counts in steroid-unresponsive idiopathic immune thrombocytopenic purpura after short-course therapy with recombinant alpha 2b interferon.

Authors:  S J Proctor; G Jackson; P Carey; A Stark; R Finney; P Saunders; G Summerfield; D Maharaj; A Youart
Journal:  Blood       Date:  1989-11-01       Impact factor: 22.113

6.  Intravenous immunoglobulin versus oral corticosteroids in acute immune thrombocytopenic purpura in childhood.

Authors:  P Imbach; H P Wagner; W Berchtold; G Gaedicke; A Hirt; P Joller; C Mueller-Eckhardt; B Müller; E Rossi; S Barandun
Journal:  Lancet       Date:  1985-08-31       Impact factor: 79.321

7.  Steroid treatment of idiopathic thrombocytopenic purpura in children. Preliminary results of a randomized cooperative study.

Authors:  J A Sartorius
Journal:  Am J Pediatr Hematol Oncol       Date:  1984

8.  Anti-D immunoglobulin in the treatment of idiopathic thrombocytopenic purpura.

Authors:  L Krishnamurti; V D Charan; N Desai; H Pati; V P Choudhry
Journal:  Indian J Pediatr       Date:  1994 Mar-Apr       Impact factor: 1.967

9.  Intravenous anti-D treatment of immune thrombocytopenic purpura: analysis of efficacy, toxicity, and mechanism of effect.

Authors:  J B Bussel; J N Graziano; R P Kimberly; S Pahwa; L M Aledort
Journal:  Blood       Date:  1991-05-01       Impact factor: 22.113

10.  Prednisone therapy for children with newly diagnosed idiopathic thrombocytopenic purpura. A randomized clinical trial.

Authors:  G R Buchanan; C A Holtkamp
Journal:  Am J Pediatr Hematol Oncol       Date:  1984
View more
  1 in total

Review 1.  Immunoglobulin therapy in immunohematological disorders.

Authors:  V P Choudhry; M Mahapatra; R Kashyap
Journal:  Indian J Pediatr       Date:  1998 Sep-Oct       Impact factor: 1.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.